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It is well established that the syndrome known as "runt disease", "homol- 
ogous disease", or "secondary disease" can be produced by the introduction of 
immunologicaily competent lymphoid ceils into allogeneic (homologous) indi- 
viduals incapable of rejecting the donor cells. This syndrome has been produced 
in newborn mice (1),  in adult mice previously made tolerant of the injected 
lymphoid ceils  (2),  in adult mice pretreated with lethal doses of x-irradiation 
(3),  and in  F1 hybrid mice injected with parental strain lymphoid cells  (4). 
These diverse experimental preparations have three characteristics in common: 
(a)  the injected donor cells are immunologically competent; (b)  the recipient 
animal is unable to reject the donor cells; and (c) the donor cells are injected 
into a recipient which differs at strong histocompafibillty loci from the donor. 
The purpose of this paper is to describe a form of runt disease in mice which 
is produced by the injection of immunologieally competent lymphoid cells into 
tolerant recipient mice of the same strain as the cell donors; the recipient mice, 
however, are lymphoid chimeras because of the prior induction of a  tolerant 
• state. In this form of runt disease, the injected syngeneic (isologous)  lymphoid 
cells  are  presumably capable  of immunologic attack only on  the  ailogeneic 
lymphoid cells present  in  the  recipient,  and not  against  the  tissues  of the 
recipient itself. We will show further that tolerant recipient mice which are not 
lymphoid chimeras escape runting after injection with immunologically compe- 
tent syngeneic lymphoid cells.  These  experimental findings indicate that an 
immunologic attack upon lymphoid and hematopoietic tissues, in the absence 
of attack against other tissues, is sufficient to cause runting. 
We  will also  show  that  whereas  the  immunologic rejection  of allogeneic 
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lymphoid  and  hematopoietic  cells present  in  chimeras  results  in  runting,  the 
rejection  of  similar  cells  which  have  not  become  established  in  host  tissues 
does not result in runting.  We therefore conclude that runting will occur only if 
the attacked cells are established within host tissues. 
Materials and Methods 
Mice.--Highly inbred  mice of the A  and  C3H/Bi strains  and  F~ hybrid  mice resulting 
from the cross between the A and C57BL/1 and the C3H and A strains have been used for 
these experiments. The A, C3H, and C57BL/1 strains have been maintained in our colony 
by strict brother-sister mating since 1956, and are directly descended from the inbred colony 
of the late Dr. J. J. Bittner. 
Irradiation.--Mice  were given total body  x-irradiation in a  compartmented  lucite con- 
tainer with plywood surround.  The factors were: 220 kv, half value layer 0.89  mm copper, 
15 ma, distance 60 cm, 1.0 mm aluminum plus 0.25 mm copper filtration. 
Skin Grafting.--Grafting of allogeneic skin was performed by the method routinely em- 
ployed in  this  laboratory  (5).  Grafts  of abdominal  skin approximately  2  cm  square  were 
rotated  180 degrees and  sutured  onto the  back  of  recipient  mice with  5--0 surgical  silk. 
No bandages or dressings  of any kind were used.  For at least 4 weeks after grafting,  mice 
were housed individually in plastic cages with free access  to Purina laboratory chow and tap 
water.  Grafts were inspected twice weekly and were considered fully accepted if the grafts 
had maintained at least their original size and if the entire graft was growing hair in a direc- 
tion opposite that of the hair on the surrounding host skin. 
Viable Spleen Cell Suspemions.--Spleen  cell suspensions  were prepared by slicing spleens 
into 5 or 6 pieces and  then expressing the splenic pulp gently from the capsule in a  loose- 
fitting Potter-Elvehjem tissue homogenizer. All suspensions  were prepared in lactate-Ringer's 
solution and were injected within 1 hour after preparation. 
Disrupted Spleen Cell Suspensicm.--Homogenates  of spleen cells were prepared in a tight- 
fitting tissue  homogenizer containing  lactate-Ringer's solution  and  then  subjected  to  four 
cycles of freezing and thawing as previously described (6).  The spleen cell suspensions  were 
checked under the microscope for the presence of intact cells following staining with trypan 
blue. In no instance could intact cells be detected after this treatment. 
Induction of Tolerance with Viable Spleen Cells.-- 
A strain mice: Two-month-old mice of the A strain were made tolerant of (A X  C57BL/1)F1 
hybrid  skin  grafts  by submitting them  to  600  roentgen  in  air of total body x-irradiation 
followed immediately by an intravenous infusion of 200  million  (A  X  C57BL/1)F1 hybrid 
spleen cells into a lateral vein of the tail. Two weeks later these mice received F~ hybrid skin 
grafts. They were used for further experimentation 4 weeks after grafting if the grafts had 
been fully accepted. 
C3H strain mice: Newborn mice of the C3H strain were made tolerant of A skin grafts by 
injecting them intravenously via the orbital branch of the facial vein within 24 hours after 
birth with 3 to 5 million viable spleen cells obtained from adult A strain donors. These mice 
were grafted with A strain skin at 5 weeks of age and were used for further experimentation 
6 weeks after grafting if the grafts had been fully accepted. 
Induction of Tolerance with Disrupted Spleen Cell Suspensions.--C3H  mice were injected 
intraperitoneally with disrupted spleen material obtained from adult A strain mice according 
to the following schedule: during the 1st week of life, mice received 0.1 of a spleen equivalent 
of the disrupted spleen material divided into two injections, one given within 24 hours after 
birth and the other 3 days later. During the 2nd,  3rd, and 4th weeks mice received a total of 
0.2, 0.4,  and  1.0 of a spleen equivalent respectively, given by twice weekly injections 3 days HENRY  R.  HILGARD,  CARLOS  MARTINEZ,  ROBERT  A.  GOOD  1019 
apart.  Mice were grafted with A skin at 5 weeks of  age and were used for further experi- 
mentation 6 to 12 weeks after grafting if the grafts were fully accepted. 
Inducaon of Runt Disease in Tolerant mice.-- 
A strain mice tolerant of (A X  C57BL/1)FI hybrid skin grafts: One group of tolerant  mice 
received an intraperitoneal  injection of 250 million spleen cells from normal  adult A strain 
donors. A second group was injected intraperitoneally  with 250 million spleen cells from A 
strain  donors which had been immunized 1 month previously to C57BL/1  tissue by a single 
intraperitoneal  injection of 50 million C57BL/1 spleen cells. A third group  was injected with 
250 million (A X  C57BL/1)Fx hybrid spleen cells. 
C3H mice tolerant of A strain skin grafts: To facilitate a graft versus host  reaction in this 
strain  combination, all tolerant  C3H mice were given sublethal  x-irradiation of 400 r in air 
immediately prior to the injection of donor spleen cells. Three  groups  of C3H mice made 
tolerant  of A by the injection of viable A strain spleen cells at birth received either  (a) 400 r 
and an injection of 150 million C3H spleen cells intravenously,  or (b) 400 r and an injection 
of 150 million (C3H X  A)F1 hybrid spleen cells intravenously, or (c) 400 r only. A group of 
C3H mice made tolerant  of A by the injection of disrupted  spleen material  received 400 r 
and an intravenous  injection of 150 million C3H spleen cells. Cell injections were given via 
one of the lateral veins of the tail within 1 hour after irradiation. 
Evaluation of Runt D/sease.--Miee  were evaluated  on the basis of daily weight changes 
and clinical appearance. At death, mice were examined in the gross and tissues prepared for 
microscopic examination. 
RESULTS 
Induction of Runting in A  Strain Mice Tolerant of (_,4 >( C57BL/1)F1 Hybrid 
Skin  Grafts by the  Injection  of Spleen  Cells from A  Strain  Donors.--A  strain 
mice which were  tolerant of (A  X  C57BL/1)F1 hybrid skin grafts by giving 
them  lethal  irradiation  and  an  intravenous  injection  of  200  million  hybrid 
spleen cells were used in this experiment. At the time of this experiment these 
mice were 4 months old, 8 weeks postirradiation and injection, and were bearing 
a fully accepted (A ×  C57BL/1)F1 hybrid skin graft placed 6 weeks previously. 
Each  mouse  in  a  group  of  11  mice was  injected  intraperitoneally  with  250 
million  spleen  cells from normal A  strain donors.  The mice in this group de- 
veloped significant weight loss beginning on the 8th day after injection, reaching 
a mean weight loss of 15 per cent of their preinjection body weight on the 14th 
day after injection  (Fig.  1). Ten of the 11 injected mice exhibited lethargy, a 
hunched appearance,  and ruffled fur during  the period of severe weight loss. 
Three succumbed to the disease process on days 15,  15, and 19 after injection 
(Table I). The remaining 8 mice eventually made a full recovery, and within 1 
month after injection had nearly regained their preinjecfion body weight. All 
surviving mice had  rejected  their  F1 hybrid skin grafts within  21  days after 
injection. 
To  determine  if  the  disease  process  observed  in  the  previous  experiment 
was in fact the result of an immunologic attack by the injected A strain lymph- 
oid cells  against  the hybrid lymphoid cells  of the  tolerant  recipient,  another 
group of 10 tolerant A strain mice were injected with spleen cells from A strain 1020  RUNT  DISEASE  IN  TOLEKANT  MICE 
donors immunized  4  weeks previously to  C57BL/!  tissue.  The mice in  this 
group showed acceleration of the runting process. By the 6th day after injection 
they showed a mean body weight loss of 24 per cent of their preinjection body 
weight~ and most had developed clinical evidence of disease by the 5th post- 
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FIG. 1. Body weight changes in 4-month-old A strain mice tolerant  of (A X  C57BL/1)F1 
hybrid skin grafts after injection with spleen cells of various origins. (Tolerance was induced 
at 2 months  of age by giving 600 r  of x-irradiation  and an intravenous  injection of (A X 
C57BL/1)F1  hybrid  spleen cells.) ......  -, injected  with  spleen cells from A immune 
to C57BL/1  donors; -- - -  o - -- -, injected  with spleen cells from normal A strain donors; 
and --+  , injected  with  spleen cells from  (A  X  C57BL/1)Fz  hybrid  donors.  All 
were injected intraperitoneally  on day 0 with 250 million spleen cells. 
injection day. Eight of 10 mice died, and by the 21st postinjection day surviving 
mice had rejected their hybrid skin grafts. It was apparent from the acceleration 
of the runting process achieved by the injection of immunized cells that runting 
was  the  result  of  an  immune  attack  by  the  injected  A  strain  lymphoid 
cells  against  the  (A  X  C57BL/1)F1  hybrid  lymphoid  tissue  present  in  the 
recipients.  A  group  of  9  tolerant  mice  were injected with  spleen  cells  from 
(A X  C57BL/1)F1 hybrid donors and served as cell injection  controls. These 
mice showed no  weight loss and their hybrid skin grafts remained intact. HENRY  R. HILGARD, CARLOS MARTINEZ, ROBERT  A.  GOOD  1021 
Failure of A  Strain Mice Injected with Large Quantities of (A  X  C57BL/1)F1 
Hybrid Spleen Cells to Develop Runting.--Since  the rtmting process observed in 
the previous experiments resulted from an immune attack by A strain lymphoid 
cells against (A X  C57BL/1)F1 hybrid lymphoid cells, we wished to determine 
if a similar runting process could be produced when normal A strain mice were 
in the process of attacking and rejecting a massive cellular allograft of (A X 
C57BL/1)F1 hybrid lymphoid cells. Nine 2-month-old A strain mice were each 
given intravenous injections of a total of 850 million viable (A X  C57BL/1)F1 
TABLE I 
Effect of Injection of Spleen Cells of Various Origins into A Tolerant to (A X  C57BL/1) 
Recipients* 
No. of 
mice in 
group 
11 
10 
Donor of injected 
spleen cells 
Normal A 
A immune to C57BL/1 
(A X C57BL/1) 
Recipient 
A tolerant to (A X 
C57BL/1) 
A tolerant to (A X 
C57BL/I) 
A tolerant to (A X 
CS7BL/1) 
No. deaths 
No. mice 
3/ii 
8/10 
0/9 
Day of death 
15,  15,  19 
13,  19,  20,  21, 
21,  23,  25,  28 
None 
* The recipient A strain mice were made tolerant of (A X C57BL/1)F1  hybrid skin grafts 
by giving them 600 r of x-irradiation and an intravenous injection of 200 million  hybrid spleen 
cells at 2 months of age. They were 4 months of age when used for this experiment and were 
bearing fully accepted (A X C57BL/1)F1  hybrid skin grafts. On day 0 of this experiment all 
mice received  an intraperitoneal injection of 250 million spleen cells from adult donors of the 
strain indicated. 
hybrid spleen cells  (approximately equivalent to 6  spleens). Each mouse re- 
ceived four injections of at least 200 million cells per injection v/a the lateral tail 
veins within a  48 hour period. The spleen cells were given intravenously in 
order to afford the greatest opportunity for the cells to set up a chimeric state 
in  the  recipient lymphoid tissue  similar  to  that  which  exists in mice made 
tolerant by injections of viable allogeneic lymphoid cells. These recipient mice, 
however, showed no weight loss or other evidence of clinical disease,  and in 
fact gained weight as well as non-injected control mice (Fig. 2). They rejected 
hybrid skin grafts placed on the 21st day after injection within 10 days after 
grafting, showing that they had not become tolerant to the hybrid tissue. This 
experiment,  then,  demonstrates  that  the  process  of  rejection of  a  massive 
quantity of allogeneic lymphoid cells is insufficient to cause clinical disease. We 
conclude that whereas the rejection of non-established hybrid lymphoid ceils 1022  RUNT  DISEASE  IN  TOLERANT  MICE 
causes no runting, the rejection of hybrid lymphoid cells which have become 
established in a chimeric animal results in a runting syndrome. 
Effect  of Injection of C3H Spleen Cells into  C3H Mice Tolerant of A  Strain 
Skin Grafts.--The foregoing experiments showed that runt disease can result 
from an immune attack by injected lymphoid ceils on allogeneic lymphoid tissue 
in a chimeric recipient. We therefore investigated the possibility that tolerant 
mice which were not lymphoid chimeras would escape runting when injected 
with syngeneic lymphoid cells. Because we have been unable to produce toler- 
ance in A strain mice of (A  X  C57BL/1)F1 hybrid skin by the injection of 
disrupted cell material, we used C3H mice tolerant of A strain skin grafts for 
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FIG. 2.  Body weight changes in 2-month-old A strain mice injected with 850 million (A X 
C57BL/1)F1 hybrid spleen cells given intravenously in 4 injections within a 48 hour period, 
the  last  injection  given  on  day  0. ---  o---,  A  strain mice injected with 850  million 
(A X  C57BL/1)F, hybrid spleen cells; and --  * --,  non-injected A strain mice. 
this experiment. C3H mice were made tolerant of A either by injecting them 
at birth with viable A  strain lymphoid cells or by giving them repeated in- 
jections of non-viable disrupted cell material from A strain donors. These C3H 
mice had been tolerant of A strain skin grafts for at least 6 weeks when they 
were used for this experiment. All tolerant mice were given 400 r of x-irradiation 
prior to injection of C3H spleen cells in order to facilitate an immune attack 
by the injected C3H ceils against the A strain lymphoid tissue of the recipients. 
Irradiation of recipient mice has been shown to facilitate the graft versus host 
reactivity of C3H ceils against A tissues (7), and it facilitates the production of 
runt disease in other strain combinations as well (8-10). A group of C3H mice 
tolerant by the injection of viable A strain cells at birth received 400 r of x-ir- 
radiation followed immediately by an intravenous injection of 150 million spleen 
cells from normal adult C3H donors. These mice showed significant weight loss 
after irradiation and injection (Fig. 3). On the 5th day after irradiation and in- 
jection they exhibited a mean body weight loss of 10 per cent of their prein- HENRY R.  HILGARD, CARLOS MARTINEZ, ROBERT A.  GOOD  1023 
jection  body weight.  However,  they  showed only slight  evidence  of clinical 
disease,  and regained their  initial body weight by the 20th postinjection day. 
The A  strain grafts these mice were bearing at the time of injection were all 
rejected by the 28th postinjectlon day.  Control groups of C3H mice tolerant 
by the injection of viable A  strain cells at birth received either 400 r  only, or 
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FIG. 3. Body weight changes in C3H mice tolerant of A strain skin grafts after irradiation 
and injection of spleen cells. - .....  -,  C3H tolerant  to A (tolerance resulting from in- 
jection  of viable A strain lymphoid  cells at birth)  receiving 400 r plus  150 million spleen 
cells from C3H donors; --  +  , C3H tolerant  to A (tolerance resulting  from repeated 
injections of non-viable A strain  cellular material)  receiving 400 r plus  150 million spleen 
cells from C3H donors; .....  ,  C3H  tolerant  to A  (tolerance resulting from injection 
of viable A strain  lymphoid cells at birth)  receiving 400 r  only; and -- --  n -- --  C3H 
tolerant  to A (tolerance resulting from injection of viable A strain  lymphoid cells at birth) 
receiving 400 r plus  150 million spleen cells from (C3H  X  A)Ft hybrid donors. All spleen 
cell injections were given within  1 hour after x-irradiation intraperitoneally  on day 0. 
400 r plus an intravenous injection of 150 million (A X  C3H)F1 hybrid spleen 
cells.  Mice in  these  two  groups  showed no  periods  of weight loss,  no  other 
clinical signs, and no evidence of rejection of their A  skin grafts (Table II). 
A  group of 6 C3H mice which had been injected with disrupted spleen ma- 
terial to induce tolerance to A received 400 r of x-irradiation and an intravenous 
injection of 150 million C3H spleen cells. These mice, which presumably were 
not lymphoid chimeras, showed no weight loss or clinical disease, and rejected 
their  A  strain  skin  grafts  within  28  days  after  irradiation  and  injection.  It 1024  RUNT  DISEASE  IN  TOLERANT  MICE 
appears, then, that l~ce which do not harbor viable allogeneic lymphoid cells 
escape this form of runting. 
TABLE  II 
Effect of Irradiation  and Injection of Spleen Cells on C3H Tolerant  to A  Mice* 
No. of mice 
in group  Donor of injected  spleen cells 
C3H 
C3H 
None 
(C3H  X  A)FI 
Method used to induce  tolerance in the 
C3H tolerant to A recipients 
Viable  A  strain  spleen  cells  in- 
jected at birth 
Non-viable cell material from A 
strain spleens$ 
Viable  A  strain  spleen  ceils  in- 
jected at birth 
Viable  A  strain  spleen  cells  in- 
jected at birth 
No. of tolerant 
mice exhibiting 
weight loss 
Mice in group 
5/6 
0/6 
0/9 
o19 
* All mice in all groups received 400 r  of x-irradiation.  Spleen cells were mjected intra- 
venously in a  dose of 150 million within 1 hour after irradiation. No deaths occurred in any 
experimental group. 
:~ Non-viable cellular material was given repeatedly, twice a  week, intraperitoneally, for 
the first 4 weeks of life. 
DISCUSSION 
These experiments demonstrate that runt disease can be produced by the 
injection of lymphoid cells into syngeneic recipient mice which are lymphoid 
cell chimeras. We have shown that this form of runting is the result of an 
immunologic attack  by  the  injected  lymphoid  cells  against  the  allogeneic 
lymphoid cells in the recipient, since if the donor of the injected lymphoid cells 
has been previously immunized against the allogeneic cell population of the 
recipient,  the onset of the runting process is much more rapid and the end 
result more frequently fatal. It should be emphasized that when lymphoid cells 
are injected into syngeneic tolerant recipients the only tissues of the recipient 
which can be attacked by the injected cells are the descendants of the allogeneic 
lymphoid cells used originally to induce the tolerance. In other forms of runt 
disease, the injected cells which induce runting are capable of attacking any 
or all of the tissues of the recipient, since the recipient is an animal of a different 
strain from the donor. Spleen cells were used in the present experiments for the 
induction of tolerance, so it is reasonable to assume that only cells of the lymph- 
oid and hematopoietic series have colonized the recipients. It is concluded that 
the immunologic rejection of lymphoid and hematopoietic tissue is sufficient to HENRY  R. HILGARD, CARLOS MARTINEZ,  ROBERT  A. GOOD  1025 
cause the runting syndrome. This conclusion is consistent with the finding that 
the most  characteristic  and  striking  pathologic  changes  during  runting  are 
found in the lymphoid tissues (11). Furthermore, our observation that tolerant 
animals,  if they are not lymphoid chimeras,  escape runting after the injection 
of syngeneic lymphoid ceils, also implicates the destruction of lymphoid and 
hematopoietic tissues as a critical factor in the pathogenesis of runt disease. 
Failure of body growth, which is the hallmark of the runting syndrome, also 
occurs  in  other  experimental  and  clinical  situations  in  which  depletion  of 
lymphoid tissue is a prominent finding. Mice subjected to neonatal thymectomy 
(12, 13) or given lethal irradiation and small amounts of syngeneic bone marrow 
(14) often develop growth failure and fatal wasting associated with lymphoid 
depletion. Similarly,  ataxia telangiectasia (15) and agammaglobulinemia of the 
Swiss type (16, 17) in man both involve deficient body growth and hypoplastic 
lymphoid tissues.  It is therefore tempting to speculate that these diseases and 
classical  runt  disease  have  a  common  pathogenesis  related  to  hypoplastic 
lymphoid tissue.  Recent experiments,  however, have shown that  neonatally 
thymectomized mice reared in a germfree environment do not develop growth 
failure or wasting whereas mice which are inoculated with allogeneic lymphoid 
cells in a  germfree environment  develop fatal runting  (18,  19).  It therefore 
appears that sepsis may be more important  in  the pathogenesis  of postthy- 
mectomy wasting than in classical runt disease. 
We have also shown that there is a special relationship in the tolerant animal 
of the  allogeneic  lymphoid  cells  to  their  hosts.  The  rejection  of a  massive 
cellular allograft of (A X  C57BL/1)F1 hybrid spleen ceils by normal A strain 
mice  produces  no  evidence  of  runting.  Why  then  should  the  rejection  of 
(A X  C57BL/1)Fx hybrid cells in a tolerant A strain mouse result in runting? 
Our working hypothesis is that immunologic  damage to lymphoid tissue which 
has  become  established  in  a  chimera  results  in  severe runting,  whereas  the 
rejection of non-established  lymphoid tissue is not a  life-threatening  process. 
Immunologic damage to established lymphoid tissue could cause the runting 
syndrome either by predisposing to infection or causing the liberation of toxic 
substance(s)  directly  within  the  lymphoid  tissues.  Although  Howard  and 
Woodruff (20) and Blaese et al. (21) have shown that mice during runting have 
a  severe immunologic deficit,  the finding  mentioned earlier  that runting  will 
occur in a  germ/ree  environment  suggests that infection is not the cause of 
death in runt disease. On the other hand, it has recently been shown by Ram- 
seier  and Streilein  (22) that lymphoid cells from unsensitized genetically dis- 
similar  mice when mixed and inoculated into the skin of irradiated hamsters 
provoke cutaneous hypersensitivity reactions. Such hypersensitivity reactions, 
if they occurred in the lymphoid tissues of runting animals,  could conceivably 
cause the liberation  of toxic substances which in  turn might  be sufficiently 
destructive to result in the growth failure characteristic of runting. 1026  RUNT  DISEASE  IN  TOLERANT  MICE 
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When  chimeric A  strmn mace tolerant of (A X  C57BL/I)FI hybrid skin 
grafts  are  injected  with spleen  cells  from normal A donors the  redpicnts develop 
weight loss,  clinical  evidence of runting, and death in some animals. Similar 
recipients  injected  with spleen  cells  from A  strain  donors immunized against 
C57BL/I tissue  show a more rapid onset of the runting process and increased 
mortality. Runfing in these experiments  therefore  results  from an immune 
attack by the injected  A strain  lymphoid cells  against the (A X  C57BL/1)FI 
hybrid tissue  harbored by the chimeric redpients. Since the hybrid tissues  of 
the chimeric recipients  were derived from spleen cell  populations we conclude 
that the immunologic rejection  of lymphoid and hematopoietic tissue  is suffi- 
dent to cause the runfing syndrome. 
C3H r~cc tolerant  of A  strain  skin grafts  because of the prior  injection  of 
viable or disrupted A strain  spleen material were given 400 r of x-irradiation 
and an injection  of C3H spleen ceils.  Only the chimeric C3H mice harboring 
viable A  strain  cells  developed wright loss  and clinical  evidence of disease, 
showing again that rnnting occurs only when an attack can be made against 
viable  lymphoid and hcmatopoicfic tissue. 
Normal  A  strain mice injected intravenously with  850 million (A  X 
C57BL/I)FI hybrid spleen  cells  reject  hybrid skin grafts  and do not develop 
runting, whereas the rejection  of similar  hybrid tissue  present in chimeric A 
strain  mice results  in  runting.  It  is  concluded that  runting will  occur only when 
the immunologic attack is  directed  against  lymphoid and hcmatopoictic tissue 
which has become established  witMn host tissues.  Thc possibility  that  runting 
may result  from hypersensitivity  reactions  occurring  in the lymphoid tissues  is 
discussed. 
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